Literature DB >> 30658024

Analysis of volumetric and dosimetric changes in mid treatment CT scan in carcinoma nasopharynx: implications for adaptive radiotherapy.

Amit Bahl1, Arun Elangovan1, Chinna Babu Dracham1, Satinder Kaur1, Arun Singh Oinam1, Gaurav Trivedi1, Roshan Verma2, Naresh K Panda2, Sushmita Ghoshal1.   

Abstract

OBJECTIVE: Carcinoma of nasopharynx is a radiosensitive tumor and therapeutic response during radiation treatment can result in dosimetric variations in the delivered dose to the tumor and critical organs. This study was done to evaluate the volumetric and dosimetric changes seen in tumor tissue and organs at risk in a mid treatment planning scan and its implications for adaptive replanning. Twenty patients of locally advanced carcinoma nasopharynx were evaluated. All patients were started on treatment with a baseline treatment plan on SIB-VMAT. To evaluate volumetric and dosimetric changes during treatment, a mid treatment CT scan (MTS) was taken at the 17th fraction of treatment and compared with the baseline planning CT scan (BS). Adaptive treatment plans were generated on the MTS and further treatment was continued on the adaptive plans. The mean weight loss observed at the 17th fraction of treatment was 3.4 ± 2.6 kg(Mean±S.D). The mean neck diameter at C2 level was 14.19±1.02 and 13.29 ± 1.14 cm in the BS and MTS respectively (p=0.001). The GTV 70 volume showed a 29.16% volume loss. The mean doses received by the right and left parotids were 25.45±0.98 and 24.64±3.8 Gy in the baseline treatment plan and 33.21±11.29 (p=0.054) and 31.76±8.44 Gy respectively in the MTS (p=0.016) The mean weight loss showed a statistically significant correlation with increase in the right parotid(p=0.043) and left parotid doses(p=0.024). Weight loss during treatment combined with volume changes in target tissues mandate routine adaptive replanning while treating carcinoma nasopharynx.
© 2018 Old City Publishing, Inc.

Entities:  

Keywords:  adaptive; nasopharynx; radiotherapy

Mesh:

Year:  2019        PMID: 30658024

Source DB:  PubMed          Journal:  J Exp Ther Oncol        ISSN: 1359-4117


  2 in total

1.  Initial Feasibility and Clinical Implementation of Daily MR-Guided Adaptive Head and Neck Cancer Radiation Therapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.

Authors:  Brigid A McDonald; Sastry Vedam; Jinzhong Yang; Jihong Wang; Pamela Castillo; Belinda Lee; Angela Sobremonte; Sara Ahmed; Yao Ding; Abdallah S R Mohamed; Peter Balter; Neil Hughes; Daniela Thorwarth; Marcel Nachbar; Marielle E P Philippens; Chris H J Terhaard; Daniel Zips; Simon Böke; Musaddiq J Awan; John Christodouleas; Clifton D Fuller
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-12-16       Impact factor: 7.038

2.  Multi-Organ Omics-Based Prediction for Adaptive Radiation Therapy Eligibility in Nasopharyngeal Carcinoma Patients Undergoing Concurrent Chemoradiotherapy.

Authors:  Sai-Kit Lam; Yuanpeng Zhang; Jiang Zhang; Bing Li; Jia-Chen Sun; Carol Yee-Tung Liu; Pak-Hei Chou; Xinzhi Teng; Zong-Rui Ma; Rui-Yan Ni; Ta Zhou; Tao Peng; Hao-Nan Xiao; Tian Li; Ge Ren; Andy Lai-Yin Cheung; Francis Kar-Ho Lee; Celia Wai-Yi Yip; Kwok-Hung Au; Victor Ho-Fun Lee; Amy Tien-Yee Chang; Lawrence Wing-Chi Chan; Jing Cai
Journal:  Front Oncol       Date:  2022-01-31       Impact factor: 6.244

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.